Friday, April 21, 2017 12:18:52 PM
Dilution Imminet
Increasing Expenditures to Pay Insiders = Imminent
Continued operational losses = Imminent
Continued debt = Imminent
OMHE's current business plan of focusing on lining Insider's pockets is working BRILLIANTLY
They gonna bait "my anything" for a couple of years.
Yessiree, no $80 million in revenues anytime soon.
Just a single pharmacy store in the ghetto of FL who's best "asset" is Le SCAM "anti-aging" creams.
That's what you're buying into. Pay the insiders; that's the plan. Working ALREADY w/ those common shares that were converted to preferred shares.
OMHE will double dip on the sales of common shares to themselves.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM